US Physical TherapyUSPH -1.24%78 5-Year Yield-on-Cost % is 9.39 as of Jul. 12, 2026, which is 106% above its 10-year median of 4.56. GuruFocus rates USPH with a GF Score™ of 78/100 and a GF Value™ of $107.98 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 281 Healthcare Providers & Services companies, US Physical Therapy ranks better than 91.81% on this metric.
US Physical Therapy's yield on cost for the quarter that ended in Mar. 2026 was 9.39.
The historical rank and industry rank for US Physical Therapy's 5-Year Yield-on-Cost % or its related term are showing as below:
USPH'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.86 Med: 4.56 Max: 11.41
Current: 9.39
During the past 13 years, US Physical Therapy's highest Yield on Cost was 11.41. The lowest was 0.86. And the median was 4.56.
USPH's 5-Year Yield-on-Cost % is ranked better than 91.81% of 281
companies
in the Healthcare Providers & Services industry
Industry Median: 2.92
vs USPH: 9.39
US Physical Therapy (NYSE:USPH) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
US Physical Therapy 5-Year Yield-on-Cost % Related Terms
USPH vs NUTX, PNTG, AMN: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, US Physical Therapy's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
US Physical Therapy 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, US Physical Therapy's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where US Physical Therapy's 5-Year Yield-on-Cost % falls into.
US Physical Therapy 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
US Physical Therapy (USPH) has a 5-Year Yield-on-Cost % of 9.39 as of Jul. 12, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on US Physical Therapy and its competitors. This is 106% above median its historical median of 4.56. Over the past decade, US Physical Therapy's 5-Year Yield-on-Cost % has ranged from 0.86 to 11.41. According to the industry distribution chart, US Physical Therapy ranks #23 out of 281 companies in the Healthcare Providers & Services industry, placing it in the top 8.2%.
Is US Physical Therapy's 5-Year Yield-on-Cost % too high?
US Physical Therapy's current 5-Year Yield-on-Cost % of 9.39 is 106% above median its 10-year median of 4.56. Over the past 10 years, this metric has ranged from a low of 0.86 to a high of 11.41. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.92. US Physical Therapy's value of 9.39 is 221.6% above this industry median. Based on the distribution chart, US Physical Therapy ranks #23 out of 281 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, US Physical Therapy has a GF Score™ of 78/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does US Physical Therapy's 5-Year Yield-on-Cost % compare to NUTX and PNTG?
According to the Healthcare Providers & Services industry distribution chart, US Physical Therapy ranks #23 out of 281 companies for 5-Year Yield-on-Cost %. This places US Physical Therapy in the top 8% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.92. US Physical Therapy's value of 9.39 is 221.6% above this benchmark. Historically, US Physical Therapy's own 5-Year Yield-on-Cost % has ranged from 0.86 to 11.41 over the past decade. While the company's 10-year median is 4.56 vs. the industry median of 2.92, US Physical Therapy has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.92, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. US Physical Therapy's current 5-Year Yield-on-Cost % of 9.39 is 221.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on US Physical Therapy and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. US Physical Therapy's current 5-Year Yield-on-Cost % is 9.39, which is 106% above median its own 10-year median of 4.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is US Physical Therapy stock overvalued right now?
Based on GuruFocus' analysis, US Physical Therapy (USPH) is currently considered Significantly Undervalued. The stock's GF Value™ is $107.98, compared to a current price of $72.54 — trading 32.8% below its estimated fair value. The current 5-Year Yield-on-Cost % is 9.39, which is 106% above median its 10-year median of 4.56 and 221.6% above the Healthcare Providers & Services industry median of 2.92. US Physical Therapy's overall GF Score™ is 78/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For US Physical Therapy (USPH), the current 5-Year Yield-on-Cost % is 9.39 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is US Physical Therapy (USPH) Overvalued in 2026?
Based on GuruFocus' analysis, US Physical Therapy stock appears to be undervalued.
The current stock price of $72.54 is trading 32.8% below its estimated GF Value™ of $107.98.
GuruFocus considers US Physical Therapy to be Significantly Undervalued.
Key valuation signals for USPH:
5-Year Yield-on-Cost %: 9.39 (106% above median its 10-year median of 4.56)
GF Value™: $107.98 vs. price of $72.54 (32.8% below fair value)
Industry Position: 221.6% above the Healthcare Providers & Services median (#23 of 281)
No single metric tells the full story. See the USPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
78GF Score
Get the complete analysis for USPH
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
USPH has been successfully added to your 